Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 2/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4794903 | 0.95 | ALDH1A1 (0.41) | ALDH1A1MAPTCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL15088351 | 0.92 | HSD17B1 (0.39) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 | |
| SCHEMBL1107803 | 0.91 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 | |
| SCHEMBL22356719 | 0.91 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 | |
| SCHEMBL13017727 | 0.91 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 | |
| SCHEMBL3443345 | 0.91 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 | |
| SCHEMBL5143671 | 0.91 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 | |
| SCHEMBL21922635 | 0.91 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 | |
| SCHEMBL2929456 | 0.91 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 | |
| SCHEMBL13197684 | 0.91 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9208533-A | — | — | None | — | — | JP | disclosed |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | POWER OLEDS LIMITED (GB) | 2019-10-08 | — | — | US | disclosed |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2016-02-04 | — | — | US | disclosed |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2016-02-04 | — | — | US | disclosed |
| WO-2014167286-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LIMITED (GB) | 2014-10-16 | — | — | WO | disclosed |
| US-20110236811-A1 | CHARGE TRANSPORT LAYER AND COATING SOLUTION FOR FORMING THE SAME | XEROX CORPORATION (US) | 2011-09-29 | — | — | US | disclosed |
| US-20110236811-A1 | CHARGE TRANSPORT LAYER AND COATING SOLUTION FOR FORMING THE SAME | XEROX CORPORATION (US) | 2011-09-29 | — | — | US | disclosed |
| US-7271291-B2 | 1,3,5-tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1310539-B1 | Polymer compound and polymer light-emitting device using the same | SUMITOMO CHEMICAL CO (JP) | 2005-03-16 | — | — | EP | disclosed |
| US-6830832-B2 | Polyanilines; strong fluorescence and large charge transporting properties | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-12-14 | — | — | US | disclosed |
| US-20030165713-A1 | Polymer compound and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-09-04 | — | — | US | disclosed |
| EP-1310539-A1 | Polymer compound and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-05-14 | — | — | EP | disclosed |
| US-5891587-A | ORGANIC ELECTROLUMINESCENT DEVICE COMPRISED OF ANODE, CATHODE, STARBURST AROMATIC AMINE COMPOUND | XEROX CORPORATION (US) | 1999-04-06 | — | — | US | disclosed |
| US-5747205-A | STARBURST AROMATIC AMINES | XEROX CORPORATION (US) | 1998-05-05 | — | — | US | disclosed |
| EP-0827367-A2 | Electroluminescent devices | XEROX CORPORATION (US) | 1998-03-04 | — | — | EP | disclosed |
| JP-H09208533-A | TRIAMINE COMPOUND | IDEMITSU KOSAN CO LTD | 1997-08-12 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | HSPA4L, HSPA1A, GAPVD1 | HSD17B1 3920/4885HSD17B2 4250/4885ALDH1A1 1122/4885 |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | NAT1, SLCO2A1, SLCO2B1 | HSD17B1 1830/4885HSD17B2 1931/4885ALDH1A1 789/4885 |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | NAT1, SLCO2A1, SLCO2B1 | HSD17B1 1830/4885HSD17B2 1931/4885ALDH1A1 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.